← FDA Drug Approvals (Drugs@FDA)
APRESOLINE-ESIDRIX
NDA · New Drug Application · Sponsor: NOVARTIS
Drug application
- FDA Application #
NDA012026- Application type
- New Drug Application
- Brand name
- APRESOLINE-ESIDRIX
- Generic name
- Hydralazine Hydrochloride
- Active ingredients
- HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- NOVARTIS
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown